DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Cice G, Di Benedetto A, D’Isa S et al.
Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial.
J Am Coll Cardiol 2010;
56: 1701-1708
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.